ArticleJIMD reports2025

Correction to "Farber's Lipogranulomatosis: Multimodal Therapy With Tocilizumab and Consolidative HSCT Improves Assessment, and Long-Term Outcome".

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.